Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Not ours. :). The company that will be buying or partnering for OM and maybe IBD.

Let’s do an exercise here; Let’s pretend Pfizer is the partner/buyer, how would you feel as a large Pfizer shareholder that your company just paid 3.4 billion for Brilacidin (entireplatform) when the company who owns B is trading at 20 million market cap? So I’m saying the deal will be thoughtful and unique imo.

From my end at IPIX I think that is garbage. I think OM alone will produce that in Revs and think all other indication could produce many multiples over time.

Im just saying I think a deal will be unique to support both sides. The last thing both parties want is shareholder grief and litigation.

Based on everything I’ve seen on B I believe it is a goldmine. I expect MGMT to get that gold for me.